Conditional European marketing authorization for Zynteglo for transfusion-dependent beta-thalassemia June 4, 2019 No Comments
Jiangsu Hengrui Medicine's camrelizumab receives first approval in China for treatment of lymphoma June 3, 2019 No Comments
RSS